Literature DB >> 26641470

Using a Lean Six Sigma Approach to Yield Sustained Pressure Ulcer Prevention for Complex Critical Care Patients.

Elizabeth A Donovan1, Christine J Manta, Jennifer C Goldsack, Michelle L Collins.   

Abstract

BACKGROUND: Under value-based purchasing, Medicare withholds reimbursements for hospital-acquired pressure ulcer occurrence and rewards hospitals that meet performance standards. With little evidence of a validated prevention process, nurse managers are challenged to find evidence-based interventions.
OBJECTIVE: The aim of this study was to reduce the unit-acquired pressure ulcer (UAPU) rate on targeted intensive care and step-down units by 15% using Lean Six Sigma (LSS) methodology.
METHODS: An interdisciplinary team designed a pilot program using LSS methodology to test 4 interventions: standardized documentation, equipment monitoring, patient out-of-bed-to-chair monitoring, and a rounding checklist.
RESULTS: During the pilot, the UAPU rate decreased from 4.4% to 2.8%, exceeding the goal of a 15% reduction. The rate remained below the goal through the program control phase at 2.9%, demonstrating a statistically significant reduction after intervention implementation.
CONCLUSIONS: The program significantly reduced UAPU rates in high-risk populations. LSS methodologies are a sustainable approach to reducing hospital-acquired conditions that should be broadly tested and implemented.

Entities:  

Mesh:

Year:  2016        PMID: 26641470     DOI: 10.1097/NNA.0000000000000291

Source DB:  PubMed          Journal:  J Nurs Adm        ISSN: 0002-0443            Impact factor:   1.737


  2 in total

1.  Implementing a Pressure Injury Care Bundle in Chinese Intensive Care Units.

Authors:  Xiaoman Zhang; Zhijun Wu; Baosheng Zhao; Qi Zhang; Zhenxiang Li
Journal:  Risk Manag Healthc Policy       Date:  2021-06-04

Review 2.  Team interventions in acute hospital contexts: a systematic search of the literature using realist synthesis.

Authors:  U Cunningham; M E Ward; A De Brún; E McAuliffe
Journal:  BMC Health Serv Res       Date:  2018-07-11       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.